Ratings Vo2 Cap Holding AB

Equities

VO2

SE0016802797

Delayed Nasdaq Stockholm Other stock markets 03:17:23 15/05/2024 pm IST			5-day change	1st Jan Change
2.94 ^SEK	+2.80%		-2.00%	+0.68%

2023	Ratsave AB acquired additional minority stake in Vo2 Cap Holding AB (OM:VO2) from Oskar Sardi.	CI
2023	Vo2 Cap Holding AB (OM:VO2) entered into an agreement to acquire Madington Ab for SEK 65 million.	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The stock, which is currently worth 2024 to 0.7 times its sales, is clearly overvalued in comparison with peers.
The company's share price in relation to its net book value makes it look relatively cheap.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
With a 2024 P/E ratio at 35.75 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
VO2 CAP HOLDING AB	+0.68%	14.14M		-
VEEVA SYSTEMS INC.	+5.87%	32.94B		C
PRO MEDICUS LIMITED	+21.53%	7.83B		C-
SECTRA AB	+33.36%	4.26B		B-
EVOLENT HEALTH, INC.	-27.79%	2.74B		C-
OMNICELL, INC.	-19.53%	1.39B		B
VERADIGM INC.	-28.50%	1.27B	-	C+
LUNIT INC.	-32.48%	1.17B		-
SIMULATIONS PLUS, INC.	+10.53%	988M		C
B-SOFT CO.,LTD.	-36.79%	884M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes